Código QR

Omalizumab may protect allergic patients against COVID-19: A systematic review

Omalizumab, which downregulates the immunoglobulin E (IgE) receptor site on plasmacytoid dendritic cells and thereby increases interferon-α (INF-α) production, may shorten the duration of viral infections by enhancing the antiviral immunity.A systematic review was conducted to investigate whether pr...

Descrición completa

Gardado en:
Principais autores: Daniele Giovanni Ghiglioni, MD, ET Laura Cozzi, MD, Riccardo Castagnoli, MD, PhD, Gaia Bruschi, MD, Laura Maffeis, MD, Paola Giovanna Marchisio, MD, Gian Luigi Marseglia, MD, Amelia Licari, MD, PhD
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2023-02-01
Series:World Allergy Organization Journal
Assuntos:
COVID-19
Interferon
IFN-Alpha
Omalizumab
SARS-CoV-2
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S1939455123000017
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares